Quarterly 13F snapshot: US-listed longs only, no performance figures — 13F data cannot support them.
Reported portfolio value by quarter (15 quarters reported)
$48.3M in Q4 2022 → $126M now. Hover for any quarter.
As reported for the quarter ended June 30, 2026. Activity is the change in share count since the prior quarter's filing.
| Holding | % of portfolio | Activity | Shares | Value |
|---|---|---|---|---|
| VE Vaneck ETF Trust | 22.8% | New | 43,838 | $28.8M |
| Cerebras Systems Inc | 14.9% | New | 84,911 | $18.8M |
| PD Pearl Diver Credit Company I | 11.5% | Unchanged | 1,459,021 | $14.5M |
| Vaxcyte Inc | 11.0% | Unchanged | 239,749 | $13.9M |
| NH Nu Hldgs Ltd | 10.9% | Unchanged | 1,026,765 | $13.7M |
| PP Praxis Precision Medicines I | 9.2% | Added 38% | 34,730 | $11.6M |
| Apple Inc | 7.1% | Trimmed 26% | 31,153 | $9.01M |
| Alphabet Inc | 7.1% | Trimmed 30% | 25,154 | $8.99M |
| Dyne Therapeutics Inc | 5.5% | Trimmed 35% | 313,559 | $6.96M |
What changed each quarter, from the filings' own share counts. Largest moves first; most recent 8 quarters.
quarter ended June 30, 2026 · filed August 14, 2026
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| VE Vaneck ETF Trust | New | +43,838 | +$28.8M | 22.8% |
| Cerebras Systems Inc | New | +84,911 | +$18.8M | 14.9% |
| Sea Ltd | Exited | −128,620 | −$10.7M | — |
| Nvidia Corporation | Exited | −60,035 | −$10.5M | — |
| Microsoft Corp | Exited | −25,842 | −$9.57M | — |
| Dyne Therapeutics Inc | Trimmed | −171,186 | −$3.8M | 5.5% |
| Alphabet Inc | Trimmed | −10,635 | −$3.8M | 7.1% |
| Apple Inc | Trimmed | −11,182 | −$3.24M | 7.1% |
| PP Praxis Precision Medicines I | Added | +9,515 | +$3.19M | 9.2% |
quarter ended March 31, 2026 · filed May 14, 2026
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| Sea Ltd | New | +128,620 | +$10.7M | 9.5% |
| Alphabet Inc | New | +35,789 | +$10.3M | 9.1% |
| PP Praxis Precision Medicines I | New | +25,215 | +$8.12M | 7.2% |
| Apple Inc | Trimmed | −23,107 | −$5.86M | 9.5% |
| NH Nu Hldgs Ltd | Trimmed | −405,186 | −$5.82M | 13.1% |
| Nvidia Corporation | Trimmed | −29,071 | −$5.07M | 9.3% |
| Janux Therapeutics Inc | Exited | −362,000 | −$5M | — |
| Microsoft Corp | Trimmed | −6,587 | −$2.44M | 8.5% |
| Dyne Therapeutics Inc | Added | +67,995 | +$1.23M | 7.8% |
| Vaxcyte Inc | Trimmed | −7,251 | −$421K | 12.4% |
quarter ended December 31, 2025 · filed February 13, 2026
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| Akero Therapeutics Inc | Exited | −328,504 | −$15.6M | — |
| Avidity Biosciences Inc | Exited | −289,201 | −$12.6M | — |
| Vaxcyte Inc | New | +247,000 | +$11.4M | 9.6% |
| Apple Inc | Added | +26,040 | +$7.08M | 15.0% |
| Nvidia Corporation | Added | +34,040 | +$6.35M | 14.0% |
| Microsoft Corp | Added | +12,998 | +$6.29M | 13.2% |
| Madrigal Pharmaceuticals Inc | Exited | −13,007 | −$5.97M | — |
| Janux Therapeutics Inc | New | +362,000 | +$5M | 4.2% |
| Dyne Therapeutics Inc | Trimmed | −101,000 | −$1.98M | 6.9% |
quarter ended September 30, 2025 · filed November 14, 2025
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| Madrigal Pharmaceuticals Inc | Trimmed | −35,369 | −$16.2M | 5.1% |
| Avidity Biosciences Inc | New | +289,201 | +$12.6M | 10.7% |
| 89bio Inc | Exited | −1,153,357 | −$11.3M | — |
| Nvidia Corporation | New | +55,066 | +$10.3M | 8.7% |
| Microsoft Corp | New | +19,431 | +$10.1M | 8.5% |
| Apple Inc | New | +39,402 | +$10M | 8.5% |
| Dyne Therapeutics Inc | New | +517,750 | +$6.55M | 5.5% |
quarter ended June 30, 2025 · filed August 13, 2025
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| Sea Ltd | Exited | −307,504 | −$29M | — |
| IT Ishares Tr | Exited | −12,555 | −$7.05M | — |
| Sarepta Therapeutics Inc | Exited | −27,717 | −$1.77M | — |
| PD Pearl Diver Credit Company I | Trimmed | −200 | −$3.6K | 29.4% |
quarter ended March 31, 2025 · filed May 14, 2025
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| IT Ishares Tr | Trimmed | −36,198 | −$20.3M | 6.0% |
| Akero Therapeutics Inc | Trimmed | −82,126 | −$3.32M | 11.3% |
| Madrigal Pharmaceuticals Inc | Added | +6,835 | +$2.26M | 13.6% |
| Sarepta Therapeutics Inc | New | +27,717 | +$1.77M | 1.5% |
| 89bio Inc | Added | +236,000 | +$1.72M | 7.1% |
| Sea Ltd | Trimmed | −7,719 | −$729K | 24.6% |
quarter ended December 31, 2024 · filed February 13, 2025
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| Sea Ltd | Trimmed | −156,000 | −$16.3M | 23.9% |
| IT Ishares Tr | Trimmed | −8,328 | −$4.9M | 20.9% |
| 89bio Inc | Added | +193,225 | +$1.51M | 5.2% |
| Madrigal Pharmaceuticals Inc | Trimmed | −4,189 | −$1.29M | 9.3% |
| Akero Therapeutics Inc | Trimmed | −13,219 | −$368K | 8.3% |
quarter ended September 30, 2024 · filed November 14, 2024
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| Sea Ltd | New | +471,223 | +$44.4M | 29.0% |
| PD Pearl Diver Credit Company I | New | +1,459,221 | +$29.2M | 19.0% |
| GA Ge Aerospace | Exited | −69,083 | −$11M | — |
| IT Ishares Tr | Added | +733 | +$423K | 21.5% |
Loading...
